SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Price & Overview

FRA:1SXPDE000A3ENQ51

Current stock price

13.6 EUR
+0.12 (+0.89%)
Last:

The current stock price of 1SXP.DE is 13.6 EUR. Today 1SXP.DE is up by 0.89%. In the past month the price decreased by -10.25%. In the past year, price decreased by -42.44%.

1SXP.DE Key Statistics

52-Week Range13.26 - 30.25
Current 1SXP.DE stock price positioned within its 52-week range.
1-Month Range13.26 - 15.6
Current 1SXP.DE stock price positioned within its 1-month range.
Market Cap
2.048B
P/E
14.02
Fwd P/E
12.47
EPS (TTM)
0.97
Dividend Yield
1.33%

1SXP.DE Stock Performance

Today
+0.89%
1 Week
-1.89%
1 Month
-10.25%
3 Months
-9.04%
Longer-term
6 Months -37.74%
1 Year -42.44%
2 Years -65.96%
3 Years N/A
5 Years N/A
10 Years N/A

1SXP.DE Stock Chart

SCHOTT PHARMA AG& CO KGAA / 1SXP Daily stock chart

1SXP.DE Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to 1SXP.DE. When comparing the yearly performance of all stocks, 1SXP.DE is a bad performer in the overall market: 92.82% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

1SXP.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to 1SXP.DE. 1SXP.DE has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1SXP.DE Earnings

Next Earnings DateMay 13, 2026
Last Earnings DateFeb 11, 2026
PeriodQ1 / 2026
EPS Reported
Revenue Reported240.188M
EPS Surprise %
Revenue Surprise 2.64%

1SXP.DE Forecast & Estimates

19 analysts have analysed 1SXP.DE and the average price target is 19.93 EUR. This implies a price increase of 46.54% is expected in the next year compared to the current price of 13.6.

For the next year, analysts expect an EPS growth of -1.71% and a revenue growth 2.29% for 1SXP.DE


Analysts
Analysts76.84
Price Target19.93 (46.54%)
EPS Next Y-1.71%
Revenue Next Year2.29%

1SXP.DE Groups

Sector & Classification

Index Membership

1SXP.DE Financial Highlights

Over the last trailing twelve months 1SXP.DE reported a non-GAAP Earnings per Share(EPS) of 0.97. The EPS decreased by -2.02% compared to the year before.


Income Statements
Revenue(TTM)996.56M
Net Income(TTM)150.74M
Industry RankSector Rank
PM (TTM) 15.13%
ROA 9.26%
ROE 16.21%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%15.79%
Sales Q2Q%4.5%
EPS 1Y (TTM)-2.02%
Revenue 1Y (TTM)4.39%

1SXP.DE Ownership

Ownership
Inst Owners20.95%
Shares150.61M
Float34.64M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About 1SXP.DE

Company Profile

1SXP logo image SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.

Company Info

IPO: 2023-09-28

SCHOTT PHARMA AG& CO KGAA

Hattenbergstrasse 10

MAINZ HESSEN DE

Employees: 4775

1SXP Company Website

1SXP Investor Relations

Phone: 496131660

SCHOTT PHARMA AG& CO KGAA / 1SXP.DE FAQ

Can you describe the business of SCHOTT PHARMA AG& CO KGAA?

SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.


What is the current price of 1SXP stock?

The current stock price of 1SXP.DE is 13.6 EUR. The price increased by 0.89% in the last trading session.


Does SCHOTT PHARMA AG& CO KGAA pay dividends?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a dividend yield of 1.33%. The yearly dividend amount is currently 0.16.


What is the ChartMill rating of SCHOTT PHARMA AG& CO KGAA stock?

1SXP.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Would investing in SCHOTT PHARMA AG& CO KGAA be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1SXP.DE.


What is the employee count for 1SXP stock?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) currently has 4775 employees.